Serum pattern of circulating free leptin, bound leptin, and soluble leptin receptor in the physiological menstrual cycle Franz Geisthövel, M.D., Nicoline.

Slides:

Advertisements

Similar presentations

High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the.

Advertisements

Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States David B. Seifer, M.D., Valerie.

Longitudinal assessment of circulating insulin-like peptide 3 levels in healthy peripubertal girls Casper P. Hagen, Ph.D., Mikkel G. Mieritz, M.D., John.

Janet E. Robinson, F. I. B. S. , Melanie Wakelin, C. Stat. , Jayne E

Andrew J. Krentz, M.D., Elizabeth Barrett-Connor, M.D.

A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome? Ronit Machtinger, M.D., Joseph.

Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women Ana Direito, M.D., Sébastien.

Longitudinal assessment of circulating insulin-like peptide 3 levels in healthy peripubertal girls Casper P. Hagen, Ph.D., Mikkel G. Mieritz, M.D., John.

Janet E. Robinson, F. I. B. S. , Melanie Wakelin, C. Stat. , Jayne E

Leptin levels and luteinizing hormone pulsatility in normal cycling women and their relationship to daily changes in metabolic rate Rebecca M. Fenichel,

The normal variabilities of the menstrual cycle

Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: a retrospective case control study Arianna D'Angelo, M.D., Rachel.

Michael M. Alper, M.D. Fertility and Sterility

Ramifications of adolescent menstrual cycles ≥42 days in young adults

Rene Ecochard, M. D. , Ph. D. , Thomas Bouchard, M. D. , Rene Leiva, M

Neohormones as biomarkers of reproductive health

Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles Angela R. Baerwald, Ph.D.,

Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women.

Serum antimüllerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids Isabelle.

Modified natural cycle in in vitro fertilization

Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D

A comparison of blood spot vs

Christine L Cook, M. D. , Yong Siow, Ph. D. , Susan Taylor, B. A

Leptin levels and luteinizing hormone pulsatility in normal cycling women and their relationship to daily changes in metabolic rate Rebecca M. Fenichel,

Prevalence of premature urinary luteinizing hormone surges in women with regular menstrual cycles and its effect on implantation of frozen-thawed embryos

Changes in circulating levels and ratios of angiopoietins during pregnancy but not during the menstrual cycle and controlled ovarian stimulation Amanda.

Angela R. Baerwald, Ph. D. , Olufemi A. Olatunbosun, M. D. , Roger A

Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens

Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activity Helen Sullivan,

Robert F. Casper, M.D. Fertility and Sterility

Severity of energy-related menstrual disturbances increases in proportion to indices of energy conservation in exercising women Mary Jane De Souza, Ph.D.,

Anastrozole vs. clomiphene citrate in infertile women with ovulatory dysfunction: a phase II, randomized, dose-finding study Donald Tredway, M.D., Ph.D.,

Angela R Baerwald, B. Sc. Hon. , Gregg P Adams, D. V. M. , M. S. , Ph

Polycystic ovarian disease unmasked by pulsatile GnRH therapy in a subgroup of women with hypothalamic amenorrhea Verena Mattle, M.D., Aysen Bilgyicildirim,

Plasma matrix metalloproteinase activity during the menstrual cycle of healthy ovulatory patients who underwent tubal ligation Maher A. Abdallah, M.D.,

Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic.

Robotic-assisted laparoscopic ovarian tissue transplantation

From partner's desk to iPad

Fertility and Sterility

Vaginally administered estroprogestinic decreases serum inhibin A and inhibin B levels and reduces endometrial thickness Stefano Luisi, M.D., Lavinia.

Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis Rina Agrawal,

Characterizing the endometrium in unexplained and tubal factor infertility: A multiparametric investigation Edmond C.O. Edi-Osagie, M.D., Mourad W. Seif,

Fertile lifespan characteristics and all-cause and cause-specific mortality among postmenopausal women: the Rotterdam Study Loes Jaspers, M.D., Maryam.

Mean versus individual hormonal profiles in the menstrual cycle

CDB-2914, a novel selective progesterone receptor modulator, differentially regulates endometrial gene expression in the proliferative phase of the menstrual.

First cesarean birth and subsequent fertility

Hongxia Li, M. D. , Steven T Nakajima, M. D. , Jiangang Chen, M. D

Why do couples discontinue in vitro fertilization treatment

Vasiliki A. Moragianni, M. D. , M. S. , Stephanie-Marie L. Jones, M. D

Regulation of assisted reproductive technologies in the United States

Decreased levels of interleukin-18 in peritoneal fluid but not in serum of patients with endometriosis Xinmei Zhang, M.D., Jun Lin, M.D., Yuli Qian,

Circulating microRNAs as potential biomarkers for endometriosis

Fertility and Sterility: an evaluation

Menstrual status and serum leptin levels in anorectic and in menstruating women with low body mass indexes Costantino Di Carlo, M.D., Giovanni A Tommaselli,

Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.

George M Butterstein, Ph.D., V.Daniel Castracane, Ph.D.

Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization Efstratios M Kolibianakis, M.D., Kostas.

Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection.

In vivo regulation of mRNA expression of vascular endothelial growth factor receptors (KDR and flt-1) in the human oviduct Po Mui Lam, M.R.C.O.G., Christine.

Hysteroscopy: a technique for all

Soluble HLA-G in the peritoneal fluid of women with endometriosis

Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation Reshef.

Anastrozole single-dose protocol in women with oligo- or anovulatory infertility: results of a randomized phase II dose–response study Donald Tredway,

Transient hyperandrogenemia and its relation to ovulation

Effect of methotrexate exposure on subsequent fertility in women undergoing controlled ovarian stimulation Janet F. McLaren, M.D., Richard O. Burney,

Conversion from assisted reproductive technology to intrauterine insemination in low responders: Is it advantageous? John M. Norian, M.D., Eric D. Levens,

Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome Ernesto Bosch,

Thyroid function after controlled ovarian hyperstimulation in women with and without the hyperstimulation syndrome Kris Poppe, M.D., Ph.D., David Unuane,

Prospective randomized double-blind trial of the correlation between time of administration and antiestrogenic effects of clomiphene citrate on reproductive.

Prevalence of hyperprolactinemia and abnormal magnetic resonance imaging findings in a population with infertility Irene Souter, M.D., Lina M. Baltagi,

Presentation transcript:

Serum pattern of circulating free leptin, bound leptin, and soluble leptin receptor in the physiological menstrual cycle Franz Geisthövel, M.D., Nicoline Jochmann, M.D., Adji Widjaja, M.D., Rüdiger Horn, B.Sc., Georg Brabant, M.D. Fertility and Sterility Volume 81, Issue 2, Pages 398-402 (February 2004) DOI: 10.1016/j.fertnstert.2003.06.020

FIGURE 1 Median (solid line) and 95% confidence intervals (dashed lines) of circulating LH (A), E2 (B), P (C), and fL (D) during three consecutive physiological menstrual cycles. Days of cycle: M 1, the first day of menstruation; LHp 0, day of the peak of circulating LH; M−10/M−6 of the first cycle are equivalent to LHp +4/+8 of the second cycle; * vs. **: M−6/LHp+8 vs. M+4; P<.001. Geisthövel. Circacyclic fluctuations of free leptin.Fertil Steril 2004. Fertility and Sterility 2004 81, 398-402DOI: (10.1016/j.fertnstert.2003.06.020)